Complex biological structures are difficult to create
R&D Focus
Customized 3D bioprinting
Innovative Solution
Brinter’s main product is the a Bioprinter, a multi-material printer that can be scaled up for mass production. The platform is unique in the medical market due to its high modularity and authentic printing capabilities
Solution Effectiveness
Brinter offers a personalized medicine approach using the patient’s cells and the body’s repair mechanisms
Nanoform, University of Glasgow, Johannes Gutenberg University of Mainz, University of Oulu
People
Founders
Tom Alapaattikoski
Tomi Kalpio
CEO
Tom Alapaattikoski
Products
Product
Brinter
Star Product
Brinter
Demo Product or Complete Product?
Complete Product
Future Plan
Market Expansion
Raised via a seed funding round led by early-stage VC firm Innovestor, the capital is set to be used as a means of expanding the company’s operations, allowing it to more easily address the U.S. and European medical markets
Investment Funding
Brinter is looking to acquire additional innovations and companies in the bioimplant space to expand its portfolio, while simultaneously finishing up their fundraising
Awards and Recognitions
Media Apperance
Biopharma Trend, VoxelMatters
M&A and Collabs
Collab
Major distribution partnership signed between Brinter and LEC
Collab
Brinter collaboration with SRM AP University in India
